The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others
OneSource Specialty Pharma announced the appointment of three new non-executive independent directors to its Board — Dr Claudio Albrecht, Debarati Sen and Vijay Karwal—effective February 27, 2025. The directors bring decades of leadership experience and expertise in Pharma, Business Strategy, Transformation, Merger & Acquisition (M&A) among others. These appointments align with the group’s philosophy of having a strong and independent board with exceptional industry experts, ensuring strategic guidance and effective governance.
With the appointment of these non-executive directors, the OneSource Board now comprises:
Chairperson: Arun Kumar – Founder & Non-Executive Director
Independent Directors:
· Dr Claudio Albrecht – Non-Executive Independent Director
· Debarati Sen – Non-Executive Independent Director
· Rashmi H Barbhaiya – Non-Executive Independent Director
· Vijay Karwal – Non-Executive Independent Director
Non-Independent Directors:
· Bharat D Shah – Non-Executive, Non-Independent Director
· Neeraj Sharma – CEO and Managing Director
Neeraj Sharma, CEO, OneSource said, “I am delighted to welcome Debarati Sen, Dr Claudio Albrecht, and Vijay Karwal, to our Board. Their expertise, strategic leadership, and global market insights will support us as we embark on the next chapter of our growth journey. Each of them will bring a new perspective that aligns perfectly with our aspiration to position OneSource as a global leader in the CDMO sector. I am confident that their contributions will not only help us achieve greater heights in corporate governance but also help us build a world-class business. I would also like to thank Rajashri Ojha, Bhushan Bopardikar, Dr Gopakumar Nair, Mahadevan N for their valuable contribution to OneSource as they step down from the board. Each of them has played a pivotal role in our journey since inception right up to our listing.”
